Literature DB >> 10383411

Mannose polyethylenimine conjugates for targeted DNA delivery into dendritic cells.

S S Diebold1, M Kursa, E Wagner, M Cotten, M Zenke.   

Abstract

Cell surface-bound receptors represent suitable entry sites for gene delivery into cells by receptor-mediated endocytosis. Here we have taken advantage of the mannose receptor that is highly expressed on antigen-presenting dendritic cells for targeted gene transfer by employing mannosylpolyethylenimine (ManPEI) conjugates. Several ManPEI conjugates were synthesized and used for formation of ManPEI/DNA transfection complexes. Conjugates differed in the linker between mannose and polyethylenimine (PEI) and in the size of the PEI moiety. We demonstrate that ManPEI transfection is effective in delivering DNA into mannose receptor-expressing cells. Uptake of ManPEI/DNA complexes is receptor-specific, since DNA delivery can be competed with mannosylated albumin. Additionally, incorporation of adenovirus particles into transfection complexes effectively enhances transgene expression. This is particularly important for primary immunocompetent dendritic cells. It is demonstrated here that dendritic cells transfected with ManPEI/DNA complexes containing adenovirus particles are effective in activating T cells of T cell receptor transgenic mice in an antigen-specific fashion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10383411     DOI: 10.1074/jbc.274.27.19087

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  Targeting vaccines to dendritic cells.

Authors:  Camilla Foged; Anne Sundblad; Lars Hovgaard
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

2.  Engineering clustered ligand binding into nonviral vectors: alphavbeta3 targeting as an example.

Authors:  Quinn K T Ng; Marie K Sutton; Pan Soonsawad; Li Xing; Holland Cheng; Tatiana Segura
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

Review 3.  Engineering biomaterial systems to enhance viral vector gene delivery.

Authors:  Jae-Hyung Jang; David V Schaffer; Lonnie D Shea
Journal:  Mol Ther       Date:  2011-05-31       Impact factor: 11.454

4.  Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.

Authors:  Hamilton Kakwere; Elizabeth S Ingham; Riley Allen; Lisa M Mahakian; Sarah M Tam; Hua Zhang; Matthew T Silvestrini; Jamal S Lewis; Katherine W Ferrara
Journal:  Bioconjug Chem       Date:  2017-10-13       Impact factor: 4.774

Review 5.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

6.  Synthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNA.

Authors:  Najung Kim; Dahai Jiang; Ashley M Jacobi; Kim A Lennox; Scott D Rose; Mark A Behlke; Aliasger K Salem
Journal:  Int J Pharm       Date:  2011-08-12       Impact factor: 5.875

Review 7.  Gene therapy of cystic fibrosis: the glycofection approach.

Authors:  I Fajac; P Briand; M Monsigny
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

8.  Engineering a polymeric gene delivery vector based on poly(ethylenimine) and hyaluronic acid.

Authors:  Clark J Needham; Austin K Williams; Sue Anne Chew; F Kurtis Kasper; Antonios G Mikos
Journal:  Biomacromolecules       Date:  2012-04-11       Impact factor: 6.988

9.  DNA nanoparticles with core-shell morphology.

Authors:  Preethi L Chandran; Emilios K Dimitriadis; Julianna Lisziewicz; Vlad Speransky; Ferenc Horkay
Journal:  Soft Matter       Date:  2014-08-19       Impact factor: 3.679

10.  Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung.

Authors:  Mini Thomas; James J Lu; Qing Ge; Chengcheng Zhang; Jianzhu Chen; Alexander M Klibanov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.